Multidisciplinary Masterclass in Oncology - Summer edition

Course Leadership

Chair - F. Lordick (DE)

Host Chair - E. Razis (GR)

Online Programme Chair - B. Jereczek (PL/IT)

Ambassador - L. Papadopoulos (GR)

Course Overview

This Multidisciplinary Masterclass in Oncology is an intensive, practice-oriented course designed for specialists involved in oncology with 2–3 years of experience, such as:

The programme has been structured around learning outcomes drawn from published international curricula across all oncology-related specialties. Sessions are aligned with globally recognised educational frameworks, ensuring relevance and consistency for all oncology professionals. It is designed to strengthen their skills in the multidisciplinary management of cancer, while promoting international collaboration and knowledge exchange.

Course Format

The Masterclass is divided into two complementary parts:

Part 1 – Online Lectures

Available from 8 May 2026

Participants will access pre-recorded lectures. This allows flexible, self-paced preparation ahead of the in-person sessions.

Part 2 – In-Person Event

19-23 June 2026

A 3.5-day residential-style course that fosters active discussion and network-building, offering direct access to experienced faculty in a collaborative and informal environment.

The Masterclass features:

Plenary lectures: State-of-the-art treatments presented by renowned international faculty, with reference to the latest clinical guidelines
Multidisciplinary interactive discussions: Engaging sessions where participants and experts from different oncology specialties collaborate and exchange perspectives
Interactive workshops: Focused on real-world practice and decision-making
Tumour board simulation: Each participant presents and discusses a clinical case with a panel of top experts. In addition, parallel breakout sessions allow smaller groups to present and discuss individual cases

Language

The course will be conducted entirely in English.

Fluency in English is a requirement for admission. Translation is not provided.

Registration Fee

The course will take place at the Hygeia Hospital, Athens, Greece.

A registration fee of 250 EUR will be requested.

The fee covers:

Access to all educational sessions and course materials
4 nights’ accommodation
Daily group transfers to/from the venue
Meals as outlined in the official programme
Travel costs are not covered and must be arranged independently.

ESO College members receive a 50% discount on the registration fee.

The fee is a non-refundable contribution towards organisational costs and will not be reimbursed in the case of withdrawal or non-attendance, regardless of the reason.

ACOE accreditation

A certificate of attendance will be issued upon completion of:

75% of the online programme
100% attendance at the in-person Masterclass
Completion of the evaluation questionnaire and learning assessment test for both parts

ACOE has awarded 40 credits to this activity.
The American Medical Association (AMA) and the Accreditation Council for Continuous medical Education (ACCME) designate this type of educational activity for a maximum of 1 AMA PRA category 1 credit per hour of activity.

ESO College Credits

Participation in this masterclass grants eligibility to join the ESO College and allows existing members to earn 30 ESO College credits toward their progression.

Visit ESO College dedicated section for more information on membership and benefits.

Contacts – Organising Secretariat

Elena Fiore - efiore@eso.net

Sonia Bulgarelli - sbulgarelli@eso.net

08 May 2026

Part 1 - Multidisciplinary Masterclass in Oncology

19 Jun 2026 - 23 Jun 2026

Part 2 - Multidisciplinary Masterclass in Oncology - Summer edition

Afroditi Nonni

NKUA Medical School, GR

Alessandro Gronchi

National Cancer Institute - IRCCS Foundation, Sarcomas Surgery Unit, Milano, IT

Alexandru Eniu

Genolier Cancer Center, Clinique de Genolier, Medical Oncology Dpt., Genolier, CH

Amanda Psyrri

Attikon University Hospital, Medical Oncology Dept., Chaidari, GR

Anastasia Stergioula

IASO General Clinic, Center of Radiation Oncology, Athens, GR

Andre D'Hoore

UZ Gasthuisberg, Dept. of Surgery, Leuven, BE

Andrea Ferrari

Fondazione IRCCS Istituto Nazionale dei Tumori, Div. di Oncologia Pediatrica, Milano, IT

Andrea Gallina

EOC - Ente Ospedaliero Cantonale, Urology Dpt., Bellinzona, CH

Anes Pasic

UPMC Hillman Cancer Center Croatia, Oncology Dept., Bracak, HR

Annalisa Trama

National Cancer Institute - IRCCS Foundation, ., Milano, IT

Aristotle Bamias

ATTIKON University Hospital National & Kapodistrian University of Athens, Internal Medicine-Oncology Dpt., Athens, GR

Barbara Alicja Jereczek-fossa

University of Milan and IEO European Institute of Oncology IRCCS, Dept. of Radiotherapy, Milano, IT

Bruno Vincenzi

University Campus Bio-Medico, Medical Oncology Dpt., Rome, IT

Bruno Vincenzi

University Campus Bio-Medico, Medical Oncology Dpt., Rome, IT

Carmen Criscitiello

Humanitas Research Hospital, D, Rozzano, Milan, IT

Chiara Louisa Hempel

Universitätsspital Zürich, ., Zurich, CH

Chiara Louisa Hempel

Universitätsspital Zürich, CH

Constantinos Zamboglou

German Oncology Center, Radiation Oncology, Limassol, CY

Cristiana Sessa

Istituto Oncologico della Svizzera Italiana, Gynaecology Dpt., Bellinzona, CH

Demetris Papamichael

Nicosia, CY

Eric Van Cutsem

University Hospital Leuven, Digestive Oncology Dept., Leuven, BE

Ernest Nadal

Institut Català d'Oncologia, Medical Oncology Department, L'Hospitalet (Barcelona), ES

Ernest Nadal

Institut Català d'Oncologia, Medical Oncology Department, L'Hospitalet (Barcelona), ES

Eva Skarpidi

Evangelia Kavoura

Evangelia Razis

Hygeia Hospital, 3rd Oncology Department, Marousi, Athens, GR

Fatima Cardoso

Alges, PT

Florian Lordick

University Hospital Leipzig, University Cancer Center Leipzig (UCCL), Leipzig, DE

Francesca Del Bufalo

IRCCS Peadiatric Hospital Bambino Gesù, Cellular and Genic Therapy Dpt., Roma, IT

Franco Cavalli

Foundation for the Institute of Oncology Research (IOR), Presidenza, Bellinzona, CH

Gaya Spolverato

Azienda Ospedale Università di Padova, Surgery - Gastrointestinal Cancers Dpt., Padova, IT

Giuseppe Caruso

European Institute of Oncology, Division of Gynecologic Oncology, Milan, IT

Giuseppe Curigliano

European Institute of Oncology / University of Milan, New Drugs for Innovative Therapies Division, Milano, IT

Giuseppe Perrone

University Campus Bio-Medico, Pathology Anatomy Dpt., Roma, IT

Helena Linardou

Metropolitan Hospital, Dept. of Oncology, Athens, GR

Ian Chau

Royal Marsden Hospital, Department of Medicine, Sutton, Surrey, UK

Ian Tannock

Toronto, CA

Ioannis Boukovinas

Thessaloniki, GR

Jarushka Naidoo

Waterford Regional Hospital, Medical Oncology Dpt., Waterford, IE

Johannes Knoth

Comprehensive Cancer Center, Dept. of Radiation Oncology, Wien, AT

Juan Francisco Grau Bejar

Gustave Roussy Institute, Gynecological Cancer Translational Research Laboratory, Inserm Umr 981, Villejuif, FR

Lazaros Papadopoulos

IASO Gynecological Clinic, Breast Unit, Athens, GR

Lorenza Rimassa

IRCCS Humanitas Research Hospital, Humanitas Cancer Center, Pieve Emanuele (Milan), IT

Luca Bertolaccini

IEO, Istituto Europeo di Oncologia IRCCS, Thoracic Surgery Dpt., Milano, IT

Luminita Mitrache

Bucharest, RO

Marco Fiore

Fondazione IRCCS Istituto Nazionale dei Tumori, Surgery Dpt., Milan, IT

Maria Avgoustidou

Marie Maillard

Centre Hospitalier Universitaire Vaudois, Pathology Dpt., Lausanne, CH

Marta Porebiak

SWPS University, Faculty of Psychology, Warsaw, PL

Michel Ducreux

Institute Gustave Roussy, Oncology, Villejuif, FR

Miroslawa Puskulluoglu

Maria Sklodowska-Curie National Research Institute of Oncology, Kraków Branch, Dept. of Clinical Oncology, Krakow, PL

Monica Casiraghi

European Institute Of Oncology, Division Of Thoracic Surgery, Milan, IT

Olena Postupalenko

Kyiv City Clinical Oncology Centre, Dept. Of Minimally Invasive Surgery, Kyiv, UA

Panagiotis Vlachostergios

Iaso Thessalias General Hospital, Medical Oncology Dpt., Larissa, GR

Paolo Giovanni Casali

National Cancer Institute - IRCCS Foundation, Medical Oncology Unit 2, Milan, IT

Philip Poortmans

Iridium Netwerk & University of Antwerp, Dept. of Radiation Oncology, Wilrijk, BE

Riccardo A. Audisio

Institute of Clinical Sciences - Sahlgrenska University Hospital, Dept. of Surgery, Göteborg, SE

Sara De Dosso

Oncology Institute of Southern Switzerland (IOSI), Medical Oncology Dpt., Bellinzona, CH

Simona Volovat

Institute of Regional Oncology Iasi, Oncology Dept., Iasi, RO

Tania Fleitas Kanonnikoff

Valencia, ES

Umberto Malapelle

University of Naples Federico II, Dpt. of Public Health, Naples, IT

Ursula Vogl

Cantonal Hospital of Southern Switzerland (EOC), IOSI - Oncology Institute of Southern Switzerland, Bellinzona, CH

Veronique Vendrely

Centre Hospitalier Universitaire de Bordeaux, ., Bordeaux, FR

Yohann Loriot

Institut Gustave Roussy, Dept. of Medicine, Villejuif, FR

Applications closed

Who Should Apply

Participation in the Masterclass is by competitive application only.

A maximum of 60 participants will be selected.

Applicants should meet the following ideal criteria:

Aged up to 40 years
2–3 years’ experience in oncology, working with cancer patients
Active involvement in clinical trials or scientific research
Fluent in English
Reside within ESO’s geographical reach: Europe, Mediterranean countries, or Latin America

Priority will also be given to candidates who:

Have previously attended ESO’s Basic Principles of Oncology course

Are members of ESO’s College

How to Apply

If interested please apply online.

The application process involves completing an online questionnaire, where you will provide details about:

Your work experience and training

Your research experience and publications

Your motivation and personal commitment to participating in this activity

During the application, you will also need to upload the following documents in PDF format:

Recommendation letter: A letter from your head of department or mentor, written on official hospital letterhead and signed.

Curriculum Vitae (CV)

Clinical case: Please use the provided template available below.

Download the Clinical Case Template HERE

Applications without the required documents will not be considered. Please ensure all files are ready before starting the application form.

Selection Process

Applications are evaluated through a two-step process:

Automated Scoring: Some responses are assessed using a predefined scoring system to ensure fairness and consistency. Points are assigned based on your answers.

Committee Evaluation: Other sections, including your qualitative responses, are reviewed and scored by our selection committee.

This type of evaluation ensures a transparent and unbiased selection of top candidates for participation in this activity.

Before you start completing the online application form, please be sure you have all the requested files (CV, Recommendation letter, and Clinical Case template) ready to be uploaded to the system. Online applications will not be considered unless all the files are uploaded.

Selected participants will be notified by mid and late March 2026.

Please ensure all documents are ready before starting the online application. Incomplete submissions will not be considered.

You will be asked to accept ESO’s Data Protection Statement during the application process.

ESO COLLEGE
CREDITS

HYBRID

Athens, Greece

ONSITE:

Jun
2026

ONLINE:

May
2026